Microsoft C.E.O. Testifies That Google’s Power in Search Is Ubiquitous

Satya Nadella, Microsoft’s chief executive, testified on Monday that Google’s power in online search was so ubiquitous that even his company found it difficult to compete on the internet, becoming the government’s highest-profile witness in its landmark antitrust trial against the search giant.

In more than three hours of testimony in federal court in Washington, Mr. Nadella was often direct and sometimes combative as he laid out how Microsoft could not overcome Google’s use of multibillion-dollar deals to be the default search engine on smartphones and web browsers.

The internet was really the “Google web,” Mr. Nadella told the packed courtroom, adding that Google could now use its advantage and scale to build tools to dominate the emerging artificial intelligence industry.

The image of the chief executive of a leading tech rival — Microsoft is one of the world’s biggest public companies, valued at $2.4 trillion — saying it could not easily fight Google was striking. Mr. Nadella’s testimony underscored how entrenched Google has become in online search as the government seeks to prove that the company broke monopoly laws by striking anti-competitive deals to crush rivals.

Mr. Nadella’s appearance on the witness stand in the case — U.S. et al v. Google, which is the first monopoly trial of the modern internet era — was also a sign that the bitter rivalry between Microsoft and Google continues unfettered. Over more than two decades, the two companies have battled over online search, mobile computing, web browsing and cloud computing and dueled in multiple legal battles as they both became ever more powerful. Now the companies are locked in an increasingly intense fight over A.I.

“Despite my enthusiasm that there is a new angle with A.I., I worry a lot that this vicious cycle that I’m trapped in could get even more vicious,” Mr. Nadella said.

Regulators around the world have been working to rein in the power and reach of Google, Apple, Amazon and Meta, which owns Facebook, Instagram and WhatsApp. Last week, the Federal Trade Commission filed a lawsuit against Amazon, arguing it broke antitrust laws by squeezing merchants on its site. The F.T.C. has also filed an antitrust lawsuit against Meta, claiming it snuffed out nascent rivals, and the Justice Department has sued Google in a second case over its control of online advertising.

The 10-week Google trial is being closely watched as a referendum on whether the government can slow down Silicon Valley’s biggest companies. A Google victory could be a major rebuke of regulators who say the tech giants have too much sway over their customers, partners and start-up competitors.

At the heart of the government’s case against Google is the accusation that the company illegally cemented its monopoly in online search by paying to be the default search engine on browsers like Apple’s Safari and Mozilla’s Firefox, as well as on the home screen of smartphones. Google has argued that the default positions are not overwhelmingly powerful and that users can switch to a new search engine if they like.

But in court, Mr. Nadella said that argument was “bogus” because users generally don’t change their default search engine, even if they have the ability to do so.

“You get up in the morning, you brush you teeth and you search on Google,” he said.

Mr. Nadella said Microsoft had tried to win deals for the default positions on browsers and smartphones for Bing, its own search engine. But it had not been very successful, he said.

Microsoft introduced Bing to compete against Google in 2009. At the time, Microsoft began an aggressive public relations campaign against Google and both companies lobbied against the other with regulators in Europe and the U.S.

In 2016, the public mudslinging seemed to come to an end with Mr. Nadella and Google’s chief executive, Sundar Pichai, who were both new to their roles, declaring a détente. The rivalry had become a distraction, they said, and they had different priorities.

The testimony from Mr. Nadella showed their rivalry had continued. John Schmidtlein, Google’s lead litigator, said in his opening statement that the case was “really all about Microsoft.”

On Monday, Mr. Schmidtlein sought to undermine Mr. Nadella’s testimony by suggesting that Microsoft’s failure to compete with Google was the result of an inferior product and a lack of investment.

Mr. Schmidtlein hammered Mr. Nadella with questions about instances in which Bing had been the default on mobile phones only for users to switch back to Google. He noted that Mr. Nadella had referred to Google as “dominant,” and asked him if he could substitute for the word “popular.”

Mr. Nadella said that whether you “call it popular or dominant,” Microsoft was still competing against Google’s massive market share.

Source: https://dnyuz.com/2023/10/02/microsoft-c-e-o-testifies-that-googles-power-in-search-is-ubiquitous/

Target to shut 9 stores across 4 US states amid rising retail crime

The move, effective Oct. 21, will see the closing of one store in New York City, two in Seattle, three locations across the San Francisco and Oakland markets and three in Portland.

Target to shut 9 stores across 4 US states amid rising retail crime

Target said on Tuesday it would close nine stores across four U.S. states, including California, citing that theft and organized retail crime was threatening the security of the retailer’s employees and customers.

The move, effective Oct. 21, will see the closing of one store in New York City, two in Seattle, three locations across the San Francisco and Oakland markets and three in Portland.

Despite heavy investments in security, the company continued to face “fundamental challenges” to running the stores safely, the retailer said. It operates nearly 2,000 stores across the United States.

“We cannot continue operating these stores because theft and organized retail crime are threatening the safety of our team and guests, and contributing to unsustainable business performance,” Target said in a statement.

Theft and retail crime has become an increasingly pressing issue for U.S. retailers, with organized crime rings targeting retail inventories and causing more financial loss to companies.

 

Source: https://www.moneycontrol.com/news/world/target-to-shut-9-stores-across-4-us-states-amid-rising-retail-crime-11434871.html

No salaries for RIL chief Mukesh Ambani’s children, will earn from board meetings alone

Mukesh Ambani’s three children, twins Akash and Isha (both 31) and Anant (28), would receive only a sitting fee and a commission on the firm’s profit. This was announced by RIL in a resolution seeking shareholder approval for the appointment of Ambani’s children to the board

Isha directly holds 0.12 per cent equity shares of the company.

Mukesh Ambani’s children, Akash, Anant, and Isha, will not be paid a salary as board members of Reliance Industries Ltd (RIL). They will only receive a fee for attending board and committee meetings. All three of them are directors of RIL.

According to a PTI report, while Ambani, 66, has received no compensation from the firm since the fiscal year 2020-21, other executive directors, including his cousins Nikhil and Hital, are paid a salary, perquisites, allowances, and commission.

His three children, twins Akash and Isha (both 31) and Anant (28), would receive only a sitting fee and a commission on the firm’s profit. This was announced by RIL in a resolution seeking shareholder approval for the appointment of Ambani’s children to the board.

The terms of the appointment of RIL chairman Mukesh Ambani’s children, Akash, Anant, and Isha, to the board of Reliance Industries Limited (RIL) are the same as the ones on which his wife Nita was appointed to the board in 2014.

This means that the children will not receive a salary, but will only be paid a sitting fee for board and committee meeting. They will also not be eligible for any other remuneration or benefits from RIL, such as stock options, bonuses, or commissions.

Nita Ambani earned a sitting fee of Rs 6 lakh and a commission of Rs 2 crore in the 2022-23 fiscal year (April 2022 to March 2023), according to the company’s latest annual report.

Ambani, 66, announced last month at the company’s annual shareholders meeting that his three children, Akash, Isha, and Anant, will be appointed into Reliance’s board of directors (BoD).

He also indicated that he will remain the company’s chairman and CEO for another five years, with an emphasis on developing and empowering its ‘next-gen’ executives.

Reliance has already mailed a postal ballot to shareholders seeking approval for their appointment to the company’s board of directors.

“They shall be paid remuneration by way of fee for attending meetings of the Board or Committees thereof or for any other meetings as may be decided by the Board, reimbursement of expenses for participating in the Board and other meetings and profit-related commission,” the notice said.

Reliance has five primary verticals: the oil-to-chemical (O2C) industry, which houses the world’s largest single-location refining complex and petrochemical plants, telecom and digital business, retail (both physical and online), new energy, and recently announced financial services.

Ambani first mentioned a succession plan for the oil-to-telecom conglomerate in 2022, when he declared that each of his three children will oversee different parts of the company (Akash would oversee telecom, Isha would oversee retail, and Anant would oversee new energy).

He did not reveal Reliance’s mainstay oil-to-chemicals or O2C business division’s succession strategy.

Reliance shareholders approved Ambani’s reappointment as CEO of India’s most valuable firm at the company’s annual general meeting (AGM) last month. And, as in the previous three years, he has chosen not to be paid during this time.

Nita resigned as a Reliance director as part of the succession planning, but she has been made a permanent invitee to all board meetings – a status that none of the board members have – Mukesh Ambani and other directors need shareholders’ approval for any extension beyond their current approved terms, but she will remain on the board in perpetuity.

Source: https://www.businesstoday.in/latest/corporate/story/no-salaries-for-mukesh-ambanis-children-will-earn-from-board-meetings-alone-399810-2023-09-26

US trade commission files anti-trust lawsuit against online retailer Amazon

Attorneys general from 17 states joined the Federal Trade Commission’s suit, which accuses Amazon of harming consumers.

A worker in an Amazon fulfilment centre in Baltimore, Maryland, places products for delivery into sorting containers [File: Clodagh Kilcoyne/Reuters]
The United States Federal Trade Commission (FTC) has filed a long-anticipated anti-trust lawsuit against online retailer Amazon, accusing the company of harming consumers by stifling competition.

The lawsuit, which was joined by 17 state attorneys general and filed in Amazon’s home state of Washington, follows a four-year investigation.

“The FTC and its state partners say Amazon’s actions allow it to stop rivals and sellers from lowering prices, degrade quality for shoppers, overcharge sellers, stifle innovation, and prevent rivals from fairly competing against Amazon,” the FTC said in a statement on Tuesday.

In laying out its charges, the FTC alleged that Amazon had engaged in unfair tactics to “illegally maintain its monopoly power” over the industry of online retail.

For example, the agency accused Amazon of punishing sellers who offer lower prices elsewhere, burying them “so far down” the website’s search results “that they become effectively invisible”. The FTC also said Amazon forces sellers to use its warehouses and delivery services, inflating costs for both consumers and sellers.

The federal agency asked the court to issue a permanent injunction ordering Amazon to stop its unlawful conduct.

“Left unchecked, Amazon will continue its illegal course of conduct to maintain its monopoly power,” the FTC said in its complaint.

In response, Amazon said the FTC is “wrong on the facts and the law”. It also accused the federal agency of overreach, saying that instead of fostering competition, the FTC was stifling it.

“The practices the FTC is challenging have helped to spur competition and innovation across the retail industry and have produced greater selection, lower prices and faster delivery speeds for Amazon customers,” said David Zapolsky, Amazon’s general counsel, in a statement.

In a blog post, Amazon noted that it had 500,000 independent sellers on the platform.

“If the FTC gets its way, the result would be fewer products to choose from, higher prices, slower deliveries for consumers, and reduced options for small businesses — the opposite of what antitrust law is designed to do,” Zapolsky said.

Amazon was started in a garage in 1994 and is today worth $1.3 trillion. By some estimates, the company controls as much as 40 percent of the e-commerce market.

Tuesday’s legal filing comes on the heels of similar federal anti-trust lawsuits against Google’s parent company Alphabet and Meta, the social media company that includes Facebook, as President Joe Biden’s administration seeks to rein in what it sees as big-tech monopolies.

Source: https://www.aljazeera.com/news/2023/9/26/us-trade-commission-files-anti-trust-lawsuit-against-online-retailer-amazon

Nirma’s acquisition of majority stake in Glenmark Life Sciences to make Glenmark Pharma debt-free

Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences at a price of Rs 615 per share.

Glenmark Pharma will own 7.84% in GLS after the divestment; pursuant to the transaction, Nirma Limited will make a mandatory open offer to all public shareholders of GLS

Detergent soap maker Nirma has acquired a 75 per cent stake in Glenmark Life Sciences at an enterprise value of about Rs 7,500 crore in a deal reflective of a rising investment interest in healthcare and pharmaceutical industry, one of the world’s fastest-growing sectors.

Deal decoded

Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75 per cent stake in Glenmark Lifesciences at a price of Rs 615 per share, amounting to Rs 5,650 crore. This transaction reflects a slight 2 per cent discount compared to the current market price of Glenmark Lifesciences. The proceeds from this sale will be utilized to retire Glenmark Pharmaceuticals’s outstanding debt, which stood at Rs 4,340 crore as of FY23.

Furthermore, the board of directors is contemplating the declaration of an interim dividend of Rs 2,250 crore before finalising the transaction. The expected closing date for this deal is in FY24, subject to obtaining the necessary regulatory and shareholder approvals. Post-transaction, Glenmark Pharma will still retain a 7.84 per cent stake in Glenmark Lifesciences. Additionally, the current promoter group members of Glenmark Pharmaceuticals will be reclassified as public shareholders, relinquishing their two board seats.

In addition to the stake sale, Glenmark Pharmaceuticals and Glenmark Lifesciences have extended their business relationship for the next five years. They have amended their Active Pharmaceutical Ingredient (API) supply and purchase agreement, with Glenmark Pharmaceuticals committing to procure APIs for Glenmark Lifesciences starting from April 1, 2024. Furthermore, an amendment services agreement has been established, under which Glenmark Pharmaceuticals and its subsidiaries will provide support services to Glenmark Lifesciences for a defined period.

This transaction values Glenmark Lifesciences at approximately Rs 6,700 crore, which is equivalent to Glenmark Lifesciences’s current public market capitalization. Given the current valuation of Rs 6,700 crore and a Price-to-Earnings (P/E) ratio of 15.26, analysts anticipate that Nirma’s investment in Glenmark will yield a 7-year Return on Invested Capital (ROIC) of 14%. This calculation is based on the assumption that earnings growth over the next 7 years will closely mirror the 3-year historical Compound Annual Growth Rate (CAGR) of approximately 14 per cent , while keeping a constant P/E multiple. This expected ROIC is 200 basis points higher than the SENSEX return of approximately 12 per cent over the past decade (from 2013-2023).

The advisory team for the Nirma Group included Khaitan & Co, KPMG, BCG, Eaishman, and DAM Capital. It’s important to note that Nirma will need to make a mandatory open offer in accordance with SEBI Regulations, and the acquisition is subject to customary regulatory approvals.

Cracker of a deal for Nirma

Nirma Group has entered the Active Pharmaceutical Ingredient (API) sector with its recent acquisition of Glenmark Life Sciences, expanding its existing pharmaceutical portfolio, which includes products such as injectables, parentals, and ophthalmic items.

Within its healthcare portfolio, Nirma currently holds two significant entities: Aculife Healthcare Pvt Ltd and Stericon Pharma Pvt Ltd. Aculife Healthcare is a leading player in the infusion and injectables sector and boasts a state-of-the-art manufacturing facility spanning 550 acres near Ahmedabad. Its global presence extends to over 100 countries, with subsidiary operations in Brazil and Mexico, as well as offices in Vietnam and the Philippines.

The manufacturing facility itself comprises two plants equipped with advanced FORM FILL SEAL (FFS) technology. These plants cater to various purposes, including the production of glass injectables, a newly established facility for manufacturing Bags, Respules, Ophthalmics, and Gaseous Anesthesia, and another designated for dermatology and Oral shots.

The acquisition of Glenmark Life Sciences follows Nirma’s earlier acquisition of Stericon Pharma, a Contract Development and Manufacturing Organization (CDMO), from the private equity firm InvAscent in March 2023. Stericon Pharma specializes in the production of sterile multipurpose contact lens cleaning solutions, as well as sterile eye and nasal formulations.

“The acquisition of Glenmark Life Sciences aligns with our company’s strategic goals and positions Nirma as one of the top five independent API companies in India. This strategic move also enables us to capitalize on indigenous research and development, making a substantial contribution to the ‘Make in India’ initiative launched by the Government of India,” Hiren Patel, Managing Director of Nirma Limited said.

Glenmark Life Sciences Limited primarily engages in the development, manufacture, and marketing of APIs. The company’s product portfolio includes various therapeutic segments, such as cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It operates manufacturing facilities at Ankleshwar, Dahej, Mohol, and Kurkumbh, with research and development facilities located at Mahape, Ankleshwar, and Dahej in India. The company is also in the process of establishing an API manufacturing facility at Chincholi, Solapur.

Source: https://www.businesstoday.in/latest/corporate/story/nirmas-acquisition-of-majority-stake-in-glenmark-life-sciences-to-make-glenmark-pharma-debt-free-399435-2023-09-23

Morning Buzz: Nifty hits all-time high of 20,000, Byju’s to sell Epic, Great Learning to pay loan

Nifty hits all-time high of 20,000
The Nifty hit an all-time high of 20,000 taking 51 trading sessions to get there after breaching the 19,000 mark on June 28. The move was on account of both local and FPI flows. FPI flows have been constrained in their China investments on account of the dire outlook for its economy. A portion of those flows have come to India. Year to date FPIs have invested $15.9 billion.
(Economic Times, Mint, Business Standard, BusinessLine)

Kotak pulls mid- and small-cap recommendations
Kotak Institutional Equites has dropped recommendations on midcaps that it covers as it cannot see too many opportunities for upside beyond the BFSI space. The brokerage has removed its favourite stocks in capital goods, healthcare, QSR and real estate sectors as it says it would be incorrect to recommend stocks with low conviction and potential downside to their fair values.
(BusinessLine)

Source: https://www.forbesindia.com/article/news/morning-buzz-nifty-hits-alltime-high-of-20000-byjus-to-sell-epic-great-learning-to-pay-loan/88163/1

Jet Airways founder Naresh Goyal arrested in Rs 538 crore bank fraud case

On May 5, CBI officials conducted searches at seven locations in Mumbai, including Goyal’s residence and offices.

Jet Airways founder Naresh Goyal. (Source: File)

Jet Airways founder Naresh Goyal was arrested on Friday in the Rs 538 crore Canara Bank fraud case. Ahead of his arrest, he was questioned by the Enforcement Directorate today.

Goyal was headed to the Serious Fraud Investigation Office (SFIO) for questioning, but ED officials took him in for questioning. He had missed two previous summons by the central probe agency.

The case is based on a FIR registered by the Central Bureau of Investigation (CBI) earlier in May this year.

On May 5, CBI officials conducted searches at seven locations in Mumbai, including Goyal’s residence and offices.

Source: https://www.indiatoday.in/india/story/enforcement-directorate-questions-jet-airways-founder-naresh-goyal-rs-538-cr-bank-fraud-2429860-2023-09-01

Adani-Hindenburg issue: ‘Regulatory tools can lead to better corporate governance,’ says FM Sitharaman

Amidst complexities, Sitharaman highlighted the role of the Securities and Exchange Board of India (SEBI) in discerning genuine concerns from manipulative actions

Finance Minister Nirmala Sitharaman

Recent developments in the financial landscape, including the Hindenburg report on the Adani Group and the impending release of another report, have spurred discussions about activist short-selling and its impact. Finance Minister Nirmala Sitharaman delved into the intricacies of this phenomenon in an interview with The Economic Times, shedding light on its dynamics and the potential regulatory responses.

Sitharaman characterised activist short selling as a practice where individuals or entities strategically take positions to manipulate the valuation of a target company. This process often involves lowering the valuation and subsequently driving it up, leading to significant profits for those involved. She noted that these short sellers meticulously analyse corporate entities to assess the feasibility of their strategies, thus assuming calculated risks to achieve substantial gains.

The Finance Minister acknowledged that there are varying approaches to this practice. While some aim to exploit market dynamics for profit, others opt for similar strategies to capitalize on market fluctuations. Amidst these complexities, Sitharaman highlighted the role of the Securities and Exchange Board of India (SEBI) in discerning genuine concerns from manipulative actions. She expressed optimism that effective use of regulatory tools could contribute to enhanced corporate governance, benefiting India’s economic landscape.

Sitharaman commented, “What I’m looking at is Sebi, with what it does, is able to see from the grain from the chaff. Regulatory tools, if used properly, coming out of this can lead to better corporate governance. There is no harm if India can also benefit from better corporate governance.”

Source : https://www.businesstoday.in/latest/corporate/story/adani-hindenburg-issue-regulatory-tools-can-lead-to-better-corporate-governance-says-fm-sitharaman-396185-2023-08-30

China Evergrande first-half net loss narrows to $4.5 billion

China Evergrande Group (3333.HK), the world’s most-indebted property developer, on Sunday reported a narrower net loss for the first half of the year, thanks to a rise in revenue.

Evergrande said its January-June loss was 33 billion yuan ($4.53 billion) versus a 66.4 billion yuan loss in the same period a year earlier.

The developer is at the centre of a crisis in China’s property sector that since late 2021 has seen a string of debt defaults, unfinished homes and unpaid suppliers, shattering consumer confidence in the world’s second-largest economy.

This month, missed U.S. dollar coupon payments by China’s largest private developer, Country Garden (2007.HK), fanned concern of contagion in an economy already weakened by tepid domestic and foreign demand, faltering factory activity and rising unemployment.

In a filing on Sunday, Evergrande said first-half revenue rose 44% from a year earlier to 128.2 billion yuan, as it “actively planned for the resumption of sales and successfully seized the short boom of the property market that emerged at the beginning of the year”. Cash fell by 6.3% to 13.4 billion yuan.

Liabilities slightly dropped to 2.39 trillion yuan from 2.44 trillion yuan at the end of 2022, while total assets also shrank to 1.74 trillion yuan from 1.84 trillion yuan.

The developer posted a combined net loss of $81 billion for 2021 and 2022 in a long-overdue earnings report last month, versus an 8.1 billion yuan profit in 2020.

A traffic light is seen near the headquarters of China Evergrande Group in Shenzhen, Guangdong province, China, Sept. 26, 2021. REUTERS/Aly Song/File Photo Acquire Licensing Rights

As with Evergrande’s previous two annual financial statements, auditor Prism Hong Kong and Shanghai has not issued a conclusion on this report, citing multiple uncertainties relating to the business as a going concern, including future cashflow.

Evergrande said its ability to continue will depend on a successful implementation of an offshore debt restructuring plan, and successful negotiations with the rest of the lenders on repayment extensions.

Source: https://www.reuters.com/markets/asia/china-evergrande-h1-net-loss-narrows-45-bln-2023-08-27/

Group backed by billionaire George Soros planning expose on Indian firms: Report

A global network of investigative journalists which has the funding of billionaire George Soros is reportedly planning an ‘expose’ on certain corporate houses in India.

A group funded by billionaire George Soros is reportedly planning an ‘expose’ on certain corporate houses in India. (Photo: Reuters file)

Seven months after the US-based short seller, Hindenberg Research, came out with an explosive report on the Adani Group, the Organised Crime and Corruption Reporting Project (OCCRP), an organisation funded by figures like George Soros and the Rockefeller Brothers Fund – is planning another ‘expose’ on certain corporate houses in India, reported PTI news agency.

OCCRP is a global network of investigative journalists which “exposes crime and corruption so the public can hold power to account”, says the description on its website. The group might publish a report or a series of articles on certain corporate houses in India, said the PTI report.

It added that the ‘expose’ may involve overseas funds investing in the stocks of the corporate houses. These firms have not yet been identified but agencies are reportedly keeping a close eye on the capital market.

On its website, OCCRP lists Open Society Foundations, a philanthropic organisation established by George Soros, as one of the “institutional donors that make our work possible”. Others include the Ford Foundation, the Rockefeller Brothers Fund and the Oak Foundation.

The Hindenberg report which came out in January accused the Adani group companies of stock manipulation and accounting fraud. The stocks of the Adani Group tumbled and Gautam Adani’s position as the richest Indian in the world was dethroned by Reliance Industries Chairman and Managing Director Mukesh Ambani.

Source: https://www.indiatoday.in/india/story/group-backed-by-billionaire-george-soros-planning-expose-on-indian-firms-adani-hindenberg-2426267-2023-08-25

Exit mobile version